Labiotech.eu

News and Trends 6 Aug 2020

DBV Technologies’ Peanut Allergy Patch Suffers FDA Setback

A request for market approval of a skin patch developed by French biotech DBV Technologies to treat peanut allergy has been turned down by the FDA, which has requested more data and design changes. The response from the FDA is a blow for the company which had been working towards getting the patch onto the […]

August 6, 2020 - 3 minutesmins - By Helen Albert

News and Trends 5 Aug 2020

Oxford Nanopore’s Portable Covid-19 Test Launched in UK

UK biotech Oxford Nanopore has launched a portable test that can detect both Covid-19 and seasonal flu viruses in saliva or swabs in a little over an hour. The quick output of Oxford Nanopore’s test, called LamPORE, is expected to be a huge improvement on existing polymerase chain reaction (PCR) tests, considered the gold standard […]

August 5, 2020 - 4 minutesmins - By Victor Kotsev

Best in Biotech 3 Aug 2020

Meet 10 European Biotech Initiatives Increasing Wildlife Biodiversity

In the fight against shrinking biodiversity, biotechnology could be a lifesaver. These European biotech initiatives are making a difference for wildlife biodiversity worldwide. Human activity is having a massive impact on wildlife biodiversity. According to a global study, 75% of terrestrial ecosystems and 66% of marine ecosystems are severely altered. This threatens the extinction of […]

August 3, 2020 - 6 minutesmins - By External Contributor

Reports 30 Jul 2020

Current and Emerging Therapeutic Approaches for Autoimmune Diseases

Over 4% of the world’s population suffers from one or more of over 80 autoimmune diseases identified to date. A large variety of treatment approaches has already been developed to curb the detrimental effects of autoimmune diseases, and the market continues to flourish. In fact, it is estimated to reach a staggering value of €7.06B […]

July 30, 2020 - 3 minutesmins - By Larissa Warneck-Silvestrin

News and Trends 30 Jul 2020

Llama-Derived Nanobodies Join the Fight Against Covid-19

Newly-launched Belgian startup ExeVir Bio will develop ‘nanobodies’ that bind very precisely to key areas of the Covid-19 virus and other coronaviruses after raking in €23M in Series A. Based in Ghent, Belgium, ExeVir Bio is a spin-out of the research institute VIB established with the help of life sciences investor Fund+. Other investors include […]

July 30, 2020 - 3 minutesmins - By Victor Kotsev

News and Trends 29 Jul 2020

Covid-19 Forces Gene Therapy Companies to Shift Strategy

Amid the Covid-19 pandemic, gene therapy companies are suffering, with clinical trials delayed and investors remaining cautious in an increasingly volatile market. Yet many have set their sights on what could potentially turn into a gold mine: applying their technology to contain the spread of the novel coronavirus. The UK’s Cell and Gene Therapy Catapult […]

July 29, 2020 - 4 minutesmins - By Victor Kotsev

News and Trends 29 Jul 2020

Update: DNA Script Raises €80M to Bring Rapid DNA Synthesis to the Lab

Update on 29/07/2020: DNA Script has increased the total raised in its Series B round to €80M ($89M). The additional funds will support the commercial launch of the company’s benchtop DNA printer, which is designed to allow same-day DNA synthesis directly in the lab bench. The company is planning to launch a beta testing program […]

July 29, 2020 - 3 minutesmins - By Clara Rodríguez Fernández

Interview 29 Jul 2020

Medical Cannabis: Regulatory Issues, Patient Demand, and Pricing Changes in Germany

While the coronavirus pandemic has shaken many industries to their core, the European medical cannabis industry continues to flourish. A number of recent developments in Germany show that the demand for medicinal cannabis is growing. But the German medical cannabis industry is also facing a number of challenges, including an unmet patient demand and a […]

July 29, 2020 - 8 minutesmins - By Larissa Warneck-Silvestrin

News and Trends 28 Jul 2020

Record Series A for Italian Biotech Funds Autoimmune Therapy

Italian biotech Enthera raised €28M in Series A funding to develop its drug candidate for type 1 diabetes and inflammatory bowel disease and take it to human trials. Enthera was founded in 2016 and is the first company to ‘graduate’ from the BiovelocITA accelerator program in Milan, which is supported by French life science investor […]

July 28, 2020 - 3 minutesmins - By Helen Albert

News and Trends 27 Jul 2020

Biological Fungicide Clears Wheat of Rust Disease in European Field Trial

A fungicide derived from amoeba has proven effective at protecting wheat from rust disease and other major fungal diseases at bay. Developed by French company Amoéba, this product could provide an eco-friendly solution to a growing problem in agriculture worldwide. Every year, over 5 million tons of wheat are lost to rust disease globally, which […]

July 27, 2020 - 2 minutesmins - By Kostas Vavitsas

In Depth 27 Jul 2020

Biosensors: Monitoring Our Health Anywhere, Anytime

Biosensors are rapidly becoming part of our everyday life. As technology advances, we may soon be able to monitor many aspects of our health at home, in real time, and without needles. Traditionally used in medical practice to monitor patient status, biosensors have recently started to be broadly marketed for wellness and fitness applications. These […]

July 27, 2020 - 6 minutesmins - By Timothé Cynober

News and Trends 24 Jul 2020

Swiss Company Raises €23M to Smash Cancer with Bacteria

Basel-based T3 Pharmaceuticals has closed its third financing round, worth over €23.3M (CHF 25M), to develop a bacterial cancer therapy. Since T3 Pharma was spun off from the University of Basel in 2015, the firm has raised €37M (CHF 40M). The fundraiser included investors such as Boehringer Ingelheim Venture Fund, Reference Capital, and Wille Finance. […]

July 24, 2020 - 2 minutesmins - By Antara Mazumdar

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

DBV Technologies’ Peanut Allergy Patch Suffers FDA Setback

Oxford Nanopore’s Portable Covid-19 Test Launched in UK

Meet 10 European Biotech Initiatives Increasing Wildlife Biodiversity

Current and Emerging Therapeutic Approaches for Autoimmune Diseases

Llama-Derived Nanobodies Join the Fight Against Covid-19

Covid-19 Forces Gene Therapy Companies to Shift Strategy

Update: DNA Script Raises €80M to Bring Rapid DNA Synthesis to the Lab

Medical Cannabis: Regulatory Issues, Patient Demand, and Pricing Changes in Germany

Record Series A for Italian Biotech Funds Autoimmune Therapy

Biological Fungicide Clears Wheat of Rust Disease in European Field Trial

Biosensors: Monitoring Our Health Anywhere, Anytime

Swiss Company Raises €23M to Smash Cancer with Bacteria

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!